EU-CANADA TRADE DEAL WELCOMED IN EUROPE PHARMA SECTOR, BUT PROMPTS CONCERN IN CANADA
October 1st, 2014
Pharmaceuticals are at the heart of the ambitious trade agreement whose final details have just been agreed between the European Union (EU) and Canada, with both sides agreeing that it will improve market access and facilitate innovation for drug companies on both sides of the Atlantic. But although the deal breaks fresh ground by being a detailed free trade pact going beyond tariff abolition, concluded between the EU and a major world economy, the European Commission has been careful to downplay expectations for a similar deal with the US in the Trans-Atlantic ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.